ARCHIVES

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 17 No. 42 | November 1, 1991

Download PDF Visit The Full Archive

Related Articles

Zerhouni Appoints Two Institute Directors

September 13, 2002

NCI sponsors Year-Round Shannon Awards Program

April 4, 1996

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014

Statement Defining Cancer Control Goals, Approaches Okayed By Board

February 6, 1981

UCSD Center Designated Comprehensive; Siteman Center In St. Louis Wins Core Grant.

August 31, 2001

Attacks On Cancer, Program Peak Following Post Series; Defenders Cite Inaccuracies, Misconceptions

November 6, 1981